The HEOR Measurement Gap Pharma Can No Longer Ignore
Pharmaceutical companies need to replace dose reduction measures with direct toxicity measurement in health-economic models Dose reduction overlooks the hidden healthcare costs of steroid-toxicity. ...
In Conversation With… Ewa Olech, MD
"It's not the cumulative steroid dosage, but the toxicity the patients experience - that's what really matters." Dr Ewa Olech's journey from medical student in Poland to Senior Medical Director at ...
Why Steroid Dose Alone Cannot Define Steroid-Sparing Value in Asthma Development
Approximately 13 million people worldwide have severe, uncontrolled asthma even with optimized treatment, according to the Global Initiative for Asthma (GINA). In this population, systemic steroid ...
Four Years, Measurable Change
At ACR Convergence 2025 in Washington, DC, something became clear: the question Steritas posed four years ago about measuring and reducing steroid-toxicity has become a framework, shifting how ...
In Conversation With… Emma Culver, MBChB DPhil FRCP
"We explain to our patients that steroids will help to control the inflammation in the liver, but can cause a number of side effects in the short and longer term." Autoimmune hepatitis is an ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
